{"name": "Acclarent",
 "permalink": "acclarent",
 "crunchbase_url": "http://www.crunchbase.com/company/acclarent",
 "homepage_url": "http://www.acclarent.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "Acclarent_ENT",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": 6,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "acclarent@acclarent.com",
 "phone_number": "1-877-775-2789",
 "description": "OTC Pharmaceuticals",
 "created_at": "Thu Dec 17 22:54:52 UTC 2009",
 "updated_at": "Sun Apr 07 10:29:37 UTC 2013",
 "overview": "\u003Cp\u003EAcclarent, Inc. is a medical device company in Menlo Park, CA that was established in June of 2004. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients.\u003C/p\u003E\n\n\u003Cp\u003EAcclarent\u0026#8217;s initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplasty\u00e2\u201e\u00a2 devices. Through the Balloon Sinuplasty\u00e2\u201e\u00a2 technology and our Relieva\u00c2\u00ae product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year.\u003C/p\u003E\n\n\u003Cp\u003EThrough our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[111,
       36],
      "assets/images/resized/0007/0201/70201v2-max-150x150.png"],
     [[111,
       36],
      "assets/images/resized/0007/0201/70201v2-max-250x250.png"],
     [[111,
       36],
      "assets/images/resized/0007/0201/70201v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Counsel",
    "person":
     {"first_name": "Earl",
      "last_name": "Bright",
      "permalink": "earl-bright",
      "image":
       {"available_sizes":
         [[[112,
            150],
           "assets/images/resized/0026/8533/268533v2-max-150x150.jpg"],
          [[120,
            160],
           "assets/images/resized/0026/8533/268533v2-max-250x250.jpg"],
          [[120,
            160],
           "assets/images/resized/0026/8533/268533v2-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "William",
      "last_name": "Facteau",
      "permalink": "william-facteau",
      "image":
       {"available_sizes":
         [[[150,
            66],
           "assets/images/resized/0026/8667/268667v1-max-150x150.jpg"],
          [[250,
            110],
           "assets/images/resized/0026/8667/268667v1-max-250x250.jpg"],
          [[409,
            180],
           "assets/images/resized/0026/8667/268667v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Founder",
    "person":
     {"first_name": "Joshua",
      "last_name": "Makower",
      "permalink": "joshua-makower",
      "image":
       {"available_sizes":
         [[[125,
            150],
           "assets/images/resized/0026/8547/268547v1-max-150x150.jpg"],
          [[208,
            250],
           "assets/images/resized/0026/8547/268547v1-max-250x250.jpg"],
          [[375,
            450],
           "assets/images/resized/0026/8547/268547v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Board Director",
    "person":
     {"first_name": "John",
      "last_name": "Nehra",
      "permalink": "john-nehra",
      "image":
       {"available_sizes":
         [[[150,
            66],
           "assets/images/resized/0026/8594/268594v1-max-150x150.jpg"],
          [[250,
            110],
           "assets/images/resized/0026/8594/268594v1-max-250x250.jpg"],
          [[409,
            180],
           "assets/images/resized/0026/8594/268594v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Corp Controller",
    "person":
     {"first_name": "Oliver",
      "last_name": "Brouse",
      "permalink": "oliver-brouse",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 785000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.biosciencetechnology.com/News/FeedsAP/2009/12/j-j-unit-paying-785m-for-device-maker-acclarent/",
   "source_description": "J\u0026J unit paying $785M for device maker Acclarent",
   "acquired_year": 2009,
   "acquired_month": 12,
   "acquired_day": 17,
   "acquiring_company":
    {"name": "Johnson \u0026 Johnson",
     "permalink": "johnson-johnson",
     "image":
      {"available_sizes":
        [[[150,
           31],
          "assets/images/resized/0005/9341/59341v1-max-150x150.jpg"],
         [[221,
           47],
          "assets/images/resized/0005/9341/59341v1-max-250x250.jpg"],
         [[221,
           47],
          "assets/images/resized/0005/9341/59341v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1525-B O'Brien Drive",
    "address2": "",
    "zip_code": "94025",
    "city": "Menlo Park",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}